In overview, these studies indicate that CSF1-Fc treatment has the potential to initiate liver fibrosis resolution, but evaluation of chronic treatment regimens with existing reagents in mice is compromised by an anti-drug response. Here, CSF1 is linked to Hepatic fibrosis.